Alerts will be sent to your verified email
Verify EmailRAYLA
Raymed Labs
|
Hemo Organic
|
Zyden Gentec
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
4.33 % | -343.55 % | -24.76 % |
5yr average Equity Multiplier
|
-0.1 | 4.83 | 2.0 |
5yr Average Asset Turnover Ratio
|
0.0 | 0.56 | 0.21 |
5yr Avg Net Profit Margin
|
0.0 | -766.15 % | -137.59 % |
Price to Book
|
0.0 | 0.0 | n/a |
P/E
|
0.0 | 0.0 | n/a |
5yr Avg Cash Conversion Cycle
|
0.0 | -1382.2 Days | 785.76 Days |
Inventory Days
|
0.0 | 364.55 Days | 134.34 Days |
Days Receivable
|
0.0 | 1156.1 Days | 803.05 Days |
Days Payable
|
0.0 | 2873.52 Days | 421.99 Days |
5yr Average Interest Coverage Ratio
|
-1369.03 | -254.04 | -2.08 |
5yr Avg ROCE
|
-157.79 % | 52.28 % | -6.92 % |
5yr Avg Operating Profit Margin
|
0.0 | -746.74 % | -95.87 % |
5 yr average Debt to Equity
|
-0.41 | 1.23 | 0.68 |
5yr CAGR Net Profit
|
10.76 % | 67.03 % | -1.66 % |
5yr Average Return on Assets
|
-51.92 % | -38.14 % | -15.88 % |
Shareholdings
|
|||
Promoter Holding
|
32.27 % | 16.85 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
3.91 % | 0.0 | -17.28 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Raymed Labs
|
Hemo Organic
|
Zyden Gentec
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|